Michael Scott Sabel, MD

Michael S. Sabel, MD, FACS is the William W. Coon Collegiate Professor of Surgical Oncology in the Department of Surgery at Michigan Medicine. He completed his undergraduate training at Pennsylvania State University and obtained his medical degree from Temple University School of Medicine in Philadelphia. His general surgery residency was performed at Rush-Presbyterian-St. Lukes Medical Center in Chicago. Dr. Sabel completed an NIH-T32 research fellowship in tumor immunology and a surgical oncology fellowship at Roswell Park Cancer Institute in Buffalo, NY. Dr. Sabel joined the University of Michigan faculty in 2001. He has been listed in Best Doctors in America in Surgical Oncology every year since 2007 and has named as one of the U.S. News and World Report Top Doctors in Surgery since 2011.

Clinical Specialization:
Dr. Sabels clinical interests are in the area of surgical oncology, with special expertise in breast cancer and melanoma.

Surgical Oncology, Breast Cancer, Melanoma

University of Michigan Health participates with most health insurance plans.

Dr. Sabel's research interests focus on the immune response to cancer cell death, particularly after cryoablation (freezing) of cancer, and he is an internationally recognized expert in the field of cryo-immunology. He has several clinical trials examining cryoablation of breast cancer as well. Dr. Sabel is also focused on the identification of prognostic and predictive markers in oncology, using both serum proteomic and tissue microarray approaches, to help guide surgical and adjuvant therapy. Additionally, Dr. Sabel is interested in the use of mobile technologies to improve patient-physician communication and improve outcomes. He is the creator of two present apps; UMSkinCheck for self skin exam and early melanoma detection, and BreastCancerAlly, a mobile patient navigator app for patients with breast cancer, with several more in development.